These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 34003320)

  • 1. Structure, biochemistry, and gene expression patterns of the proline biosynthetic enzyme pyrroline-5-carboxylate reductase (PYCR), an emerging cancer therapy target.
    Bogner AN; Stiers KM; Tanner JJ
    Amino Acids; 2021 Dec; 53(12):1817-1834. PubMed ID: 34003320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PYCR in Kidney Renal Papillary Cell Carcinoma: Expression, Prognosis, Gene Regulation Network, and Regulation Targets.
    Shao Z; Lu L; Cui Y; Deng L; Xu Q; Liang Q; Lu X; Zhang J; Chen J; Situ Y
    Front Biosci (Landmark Ed); 2022 Dec; 27(12):336. PubMed ID: 36624948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening a knowledge-based library of low molecular weight compounds against the proline biosynthetic enzyme 1-pyrroline-5-carboxylate 1 (PYCR1).
    Meeks KR; Bogner AN; Tanner JJ
    Protein Sci; 2024 Jul; 33(7):e5072. PubMed ID: 39133178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resolving the cofactor-binding site in the proline biosynthetic enzyme human pyrroline-5-carboxylate reductase 1.
    Christensen EM; Patel SM; Korasick DA; Campbell AC; Krause KL; Becker DF; Tanner JJ
    J Biol Chem; 2017 Apr; 292(17):7233-7243. PubMed ID: 28258219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Proline Cycle As a Potential Cancer Therapy Target.
    Tanner JJ; Fendt SM; Becker DF
    Biochemistry; 2018 Jun; 57(25):3433-3444. PubMed ID: 29648801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PYCR, a key enzyme in proline metabolism, functions in tumorigenesis.
    Li Y; Bie J; Song C; Liu M; Luo J
    Amino Acids; 2021 Dec; 53(12):1841-1850. PubMed ID: 34273023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and kinetic characterization of PYCR3.
    Meeks KR; Tanner JJ
    Arch Biochem Biophys; 2023 Jan; 733():109468. PubMed ID: 36414121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human mitochondrial pyrroline-5-carboxylate reductase 1 promotes invasiveness and impacts survival in breast cancers.
    Ding J; Kuo ML; Su L; Xue L; Luh F; Zhang H; Wang J; Lin TG; Zhang K; Chu P; Zheng S; Liu X; Yen Y
    Carcinogenesis; 2017 May; 38(5):519-531. PubMed ID: 28379297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic human herpesvirus hijacks proline metabolism for tumorigenesis.
    Choi UY; Lee JJ; Park A; Zhu W; Lee HR; Choi YJ; Yoo JS; Yu C; Feng P; Gao SJ; Chen S; Eoh H; Jung JU
    Proc Natl Acad Sci U S A; 2020 Apr; 117(14):8083-8093. PubMed ID: 32213586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isozymes of P5C reductase (PYCR) in human diseases: focus on cancer.
    Hu CA
    Amino Acids; 2021 Dec; 53(12):1835-1840. PubMed ID: 34291342
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Christensen EM; Bogner AN; Vandekeere A; Tam GS; Patel SM; Becker DF; Fendt SM; Tanner JJ
    J Biol Chem; 2020 Dec; 295(52):18316-18327. PubMed ID: 33109600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional Impact of a Cancer-Related Variant in Human Δ
    Daudu OI; Meeks KR; Zhang L; Seravalli J; Tanner JJ; Becker DF
    ACS Omega; 2023 Jan; 8(3):3509-3519. PubMed ID: 36713721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease variants of human Δ
    Patel SM; Seravalli J; Liang X; Tanner JJ; Becker DF
    Arch Biochem Biophys; 2021 May; 703():108852. PubMed ID: 33771508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deciphering the Effects of the PYCR Family on Cell Function, Prognostic Value, Immune Infiltration in ccRCC and Pan-Cancer.
    Chen H; Chen Q; Chen J; Mao Y; Duan L; Ye D; Cheng W; Chen J; Gao X; Lin R; Lin W; Zhang M; Qi Y
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased mitochondrial proline metabolism sustains proliferation and survival of colorectal cancer cells.
    Alaqbi SS; Burke L; Guterman I; Green C; West K; Palacios-Gallego R; Cai H; Alexandrou C; Myint NNM; Parrott E; Howells LM; Higgins JA; Jones DJL; Singh R; Britton RG; Tufarelli C; Thomas A; Rufini A
    PLoS One; 2022; 17(2):e0262364. PubMed ID: 35130302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of human pyrroline-5-carboxylate reductase in L-thioproline metabolism.
    Patel SM; Seravalli J; Stiers KM; Tanner JJ; Becker DF
    Amino Acids; 2021 Dec; 53(12):1863-1874. PubMed ID: 34792644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional specialization in proline biosynthesis of melanoma.
    De Ingeniis J; Ratnikov B; Richardson AD; Scott DA; Aza-Blanc P; De SK; Kazanov M; Pellecchia M; Ronai Z; Osterman AL; Smith JW
    PLoS One; 2012; 7(9):e45190. PubMed ID: 23024808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis.
    Ding Z; Ericksen RE; Escande-Beillard N; Lee QY; Loh A; Denil S; Steckel M; Haegebarth A; Wai Ho TS; Chow P; Toh HC; Reversade B; Gruenewald S; Han W
    J Hepatol; 2020 Apr; 72(4):725-735. PubMed ID: 31726117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrroline-5-Carboxylate Reductase 1: a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis.
    Oudaert I; Satilmis H; Vlummens P; De Brouwer W; Maes A; Hose D; De Bruyne E; Ghesquière B; Vanderkerken K; De Veirman K; Menu E
    J Exp Clin Cancer Res; 2022 Feb; 41(1):45. PubMed ID: 35105345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic evidence for a common enzyme catalyzing the second step in the degradation of proline and hydroxyproline.
    Valle D; Goodman SI; Harris SC; Phang JM
    J Clin Invest; 1979 Nov; 64(5):1365-70. PubMed ID: 500817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.